133076-40-1

Basic information

• Product Name: 6-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-β-D-glucopyranosyl trichloroacetimidate
• Synonyms: 6-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-β-D-glucopyranosyl trichloroacetimidate
• CAS NO: 133076-40-1
• Molecular Weight: 571.845
• Mol File: 133076-40-1.mol

Chemical Properties

• CAS DataBase Reference: 6-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-β-D-glucopyranosyl trichloroacetimidate(CAS DataBase Reference)
• NIST Chemistry Reference: 6-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-β-D-glucopyranosyl trichloroacetimidate(133076-40-1)
• EPA Substance Registry System: 6-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-β-D-glucopyranosyl trichloroacetimidate(133076-40-1)

Safety Data

• Hazardous Substances Data: 133076-40-1(Hazardous Substances Data)

Upstream product

• 545-06-2 trichloroacetonitrile 
• 157896-03-2 6-O-Acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-β-D-glucopyranose 
• 211237-94-4 C₂₂H₂₅N₃O₆ 
• 133076-39-8 1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-β-D-glucopyranose 
• 55682-48-9 1,6-anhydro-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose 
• 245109-97-1 thexyldimethylsilyl 6-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-β-D-glucopyranoside 
• 819870-38-7 thexyldimethylsilyl 3,4,6-tri-O-acetyl-2-azido-2-deoxy-β-D-glucopyranoside 
• 157488-88-5 thexyldimethylsilyl 2-azido-2-deoxy-β-D-glucopyranoside 
• 171032-74-9 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxy-D-glucopyranose 
• 136172-58-2 1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-α,β-D-glucopyranose 

Downstream Products

• 158215-56-6 1-(6-O-Acetyl-2-azido-2-deoxy-3,4-dibenzyl-α-D-glucopyranosyl)-6-O-allyl-2,3,4,5-tetra-O-benzyl-D-chiro-inositol 
• 1262887-48-8 C₄₂H₄₅N₃O₁₂ 
• 1262887-46-6 C₅₈H₆₃N₃O₁₂Si 
• 1262887-50-2 C₆₃H₆₉N₃O₁₄Si 
• 1262887-52-4 6-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-α-D-glucopyranosyl-(1->4)-benzyl (3-O-benzyl-2-O-levulinoyl)-β-D-glucopyranosyluronate-(1->4)-(3-O-acetyl-1,6-anhydro-2-azido)-2-deoxy-β-D-glucopyranose 
• 1262887-53-5 6-O-acetyl-2-azido-2-deoxy-3,4-di-O-benzyl-α-D-glucopyranosyl-(1->4)-O-[benzyl 3-O-benzyl-2-O-levulinoyl-β-D-glucopyranosyluronate]-(1->4)-O-2-azido-2-deoxy-1,3,6-tri-O-acetyl-β-D-glucopyranose 
• 1262887-54-6 6-O-acetyl-2-azido-2-deoxy-3,4-di-O-benzyl-α-D-glucopyranosyl-(1->4)-O-[benzyl 3-O-benzyl-2-O-levulinoyl-β-D-glucopyranosyluronate]-(1->4)-O-2-azido-2-deoxy-3,6-di-O-acetyl-β-D-glucopyranose 
• 133163-53-8 O-(2-azido-3,4,6-tri-O-benzyl-2-deoxy-α-D-glucopyranosyl)-(1->4)-1,5,6-tri-O-benzyl-L-myo-inositol 
• 133076-44-5 (2-azido-3,4,6-tri-O-benzyl-2-deoxy-α-D-glucopyranosyl)-(1-6)-1-O-4-methoxybenzyl-2,3,4,5-tetra-O-benzyl-D-myo-inositol 
• 133076-43-4 (1R,2R,3S,4S,5R,6S)-3-((2R,3R,4R,5S,6R)-3-Azido-4,5-bis-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yloxy)-4,5,6-tris-benzyloxy-2-(4-methoxy-benzyloxy)-cyclohexanol 
• 133076-45-6 O-(2-azido-3,4,6-tri-O-benzyl-2-deoxy-α-D-glucopyranosyl)-(1->6)-2,3,4,5-tetra-O-benzyl-D-myo-inositol 
• 1053733-28-0 Phosphoric acid (1R,2R,3R,4R,5S,6R)-2-allyloxy-6-((2R,3R,4R,5S,6R)-3-azido-4,5-bis-benzyloxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-3,4,5-tris-benzyloxy-cyclohexyl ester dibenzyl ester 
• 158215-62-4 3,4,5-Tri-O-benzyl-1-O-(dibenzylphosphono)-6-(2-azido-2-deoxy-3,4-dibenzyl-α-D-glucopyranosyl)-D-myo-inositol 
• 158215-57-7 1-(6-O-Acetyl-2-azido-2-deoxy-3,4-dibenzyl-α-D-glucopyranosyl)-2,3,4,5-tetra-O-benzyl-D-chiro-inositol 

Relevant articles and documents

Synthesis of new fluorescently labeled glycosylphosphatidylinositol (GPI) anchors

The borondipyrromethene (BODIPY) labeled new glycosylphosphatidylinositol (GPI) molecules were synthesized as cellular probes to study the chemical basis of microdomain organization of GPI-anchored proteins and cholesterol in plasma membrane. The synthesi

PROCESS FOR PREPARING FONDAPARINUX SODIUM AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF

Processes for the synthesis of the Factor Xa anticoagulent Fondaparinux, and related compounds are described. Also described are protected pentasaccharide intermediates as well as efficient and scalable processes for the industrial scale production of Fondaparinux sodium by conversion of the protected pentasaccharide intermediates via a sequence of deprotection and sulfonation reactions.

OLIGOSACCHARIDE COMPOUNDS FOR USE IN MOBILISING STEM CELLS

A compound of the following formula or a salt, solvate or formula (I) and a pharmaceutical composition containing said compound. It concerns also its use in the treatment of cancer and/or of pathological angiogenesis and/or in promoting the mobilisation of stem cells, in particular hematopoietic stem cells.

Synthesis of disaccharidic sub-units of a new series of heparin related oligosaccharides

The chemical synthesis of disaccharides 1 and 2, useful building-blocks for the preparation of a new series of heparin related oligosaccharides containing the unusual sequence (GlcN-IdoA)(n), is described. In addition, the orthogonality of the protective groups would allow access to a wide array of differently sulfated oligosaccharides. As the simplest members of this new class of oligomer, the synthesis of sulfated disaccharides 3 and 4 fully deprotected is reported.

Synthesis of α-glucosidase inhibitors: Kojibiose-type pseudodisaccharides and a related pseudotrisaccharide

Two kojibiose-type pseudo-disaccharides and a trisaccharide, containing a 5-amino-1,2,3,4-cyclopentanetetrol derivative or valienamine, linked by way of nitrogen bridges to the sugar residues, have been designed and synthesized as processing α-glucosidase I inhibitors. Synthesis of the pseudodisaccharides was carried out starting from the coupling products of the sugar isothiocyanates and an aminocyclitol, respectively, by cyclization with mercury(II) oxide to the cyclic isoureas and subsequent deprotection. Pseudokojibiose was prepared in a poor yield by reaction of a protected valienamine and a sugar epoxide, followed by deprotection. Although the pseudooligosaccharides are all strong inhibitors of α-glucosidase (baker's yeast), they did not have any inhibitory potency against either sucrase isomaltase (rat Intestine) or processing α-glucosidase (rat liver microsomes).

An effective strategy for the synthesis of 6-O-(2-amino-2-deoxy-α-D-glucopyranosyl)-D-chiro- and -D-myo-inositol 1-phosphate related to putative insulin mimetics

Two glycosylinositol phosphates related to putative insulin mimetics, 6-O-(2-amino-2-deoxy-α-D-glucopyranosyl)-D-chiro-inositol 1-phosphate (1) and 6-O-(2-amino-2-deoxy-α-D-glucopyranosyl)-D-myo-inositol 1-phosphate (2), have been synthesized from selectively protected and enantiomerically pure D-chiro- and myo-inositol derivatives. The D-chiro-inositol unit was prepared in a multigram scale from D-glucose using the Ferrier's carbocyclization route, and it was transformed into the corresponding myo epimer by an oxidation-reduction sequence. The trichloroacetimidate method was applied efficiently for the key glycosylation of the inositol derivatives.

APPLICATION OF PHENYL 1-SELENOGLYCOSIDES IN THE SYNTHESIS OF A CELL-WALL TETRAMERIC FRAGMENT OF PROTEUS VULGARIS STRAIN 5/43

DAST-assisted rearrangement of 3-O-allyl-4-O-benzyl-α-L-rhamnopyranosyl azide followed by treatment of the generated fluorides with ethanethiol and BF3*OEt2 gave glycosyl donor ethyl 3-O-allyl-2-azido-4-O-benzyl-2,6-dideoxy-1-thio-α/β-L-glucopyranoside.St

STEREOSPECIFIC SYNTHESIS OF PARTIALLY PROTECTED 2-AZIDO-2-DEOXY-D-GLUCOSYL D-MYO-INOSITOL: PRECURSOR OF A POTENTIAL INSULIN MIMETIC AND MEMBRANE PROTEIN ANCHORING SITE

Racemic and partially protected myo-inositol derivative 5 was coupled stereospecifically with the 2-azido-2-deoxy-glucosyl trichloroacetimidate donor 8.Optical resolution of the thus obtained diastereoisomeric mixture of dimers by silica gel column chromatography, and further protective group manipulations, afforded the suitably protected title compound 14.